[CWI] SPDR MSCI ACWI ex-US

Overview

Type of security: Fund

Tags: Blend, Equity, ETF, ex-US, Index Based, Large-cap, Not Inversed, Regional, Stocks, Unleveraged

The data is delayed by 15 minutes.

 

Price: 31.32 Change: 0.02 (0.06%)
Ext. hours: Change: 0 (0%)

chart CWI

Refresh chart

Strongest Trends Summary For CWI

CWI is in the medium-term down -37% below S&P in 1 year. In the long-term down -44% below S&P in 2 years and down -72% below S&P in 15 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of an index. The fund employs a sampling strategy in seeking to track the performance of the MSCI All Country World Index ex USA. It invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in ADRs or GDRs based on securities comprising the index. The index is a float-adjusted market capitalization index that is designed to measure the combined equity market performance of developed and emerging market countries excluding the United States. The fund is non-diversified.

Technical Data
High 52 week36.72 Low 52 week22.7 Last close24.4 Last change1.04%
RSI55.37 Average true range0.25 Beta1.09 Volume391.83 K
Simple moving average 20 days1.75% Simple moving average 50 days3.06% Simple moving average 200 days-15.7%
Performance Data
Performance Week3.87% Performance Month0.55% Performance Quart-0.05% Performance Half-33.36%
Performance Year-29.58% Performance Year-to-date-25.47% Volatility daily0.87% Volatility weekly1.95%
Volatility monthly4% Volatility yearly13.85% Relative Volume191.86% Average Volume237.07 K
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization58.44 B Forward P/E13.22
Gross expense ratio Index dividend yield2.98 Median market cap Number of holdings617
Price to Book Value 1.64 Price to Earnings Total expense ratio0.34% Total net assets
Weighted market capitalization

Info

Characteristics:
NAME VALUE
Index Dividend Yield2.98
Fy1 P/E Ratio13.22
Number Of Holdings617
P/Bv Ratio1.64
Average Weighted Market Capitalization58444.39
Total Expense Ratio0.34
Top Holdings:
NAME VALUE
Roche Holding Ltd Genusssch.1.34
Nestle S.a.1.21
Novartis Ag1.13
Hsbc Holdings Plc1.08
Toyota Motor Corp.0.95
Bp P.l.c.0.90
Samsung Electronics Co. Ltd. Gdr Regs0.89
Total Sa0.88
Royal Dutch Shell Plc Class A0.86
Glaxosmithkline Plc0.86
Top Sectors:
NAME VALUE
Financials25.73
Industrials11.69
Consumer Discretionary10.79
Energy9.55
Materials8.94
Health Care8.83
Consumer Staples8.68
Information Technology6.12
Telecommunication Services5.68
Utilities3.59
Top Countries:
NAME VALUE
United Kingdom16.08
Japan14.19
Canada7.31
France7.09
Germany6.82
Switzerland6.64
Australia6.27
South Korea3.71
China3.56
Sweden2.47
Hong Kong2.37
Netherlands2.31
Spain2.25
Brazil1.86
Taiwan1.84

News

2019-11-08 13:00:06 | Emerging Market ETFs Beating the Broader Market: Here's How

2019-10-18 05:43:03 | 4 Trades to Profit During Next 12 Months of Investor 'Purgatory'

2018-10-29 17:16:22 | Bargain Hunters Should Look to Global ETFs

2018-03-14 19:05:11 | Davis Advisors Launches International Equity ETF

2018-01-23 10:06:59 | 5 Fantastic Retirement ETFs

2017-11-28 08:30:42 | 10 Minutes, 10 ETFs — And You’re All Set For 2018!

2017-05-31 12:05:49 | Using Asian Markets’ Low Correlation with US Markets

2016-12-24 13:04:04 | SPDR INDEX SHARES FUNDS FORMERLY STREETTRACKS INDEX SHARES Financials

2016-09-30 10:04:24 | Allergan Generics Has Strengthened Teva’s Research Pipeline

2016-09-28 10:05:19 | Teva Is Well Placed to Dominate the European Generics Market

2016-09-27 08:04:45 | Teva’s Generic Value Chain Differentiates It from Its Peers

2016-08-23 09:04:05 | Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016

2016-07-26 15:38:04 | 7 ETFs for a Lower Return Outlook

2016-06-14 09:05:46 | Teva Aims to Improve Its Position with Actavis Generics Acquisition

2016-05-09 15:39:41 | Quality Works For This Emerging Markets ETF

2016-04-06 09:07:15 | Teva: Developments in the Migraine Prevention Segment

2016-04-01 09:07:44 | Bendeka: How Teva Plans to Safeguard Oncology Revenues

2016-03-03 09:30:02 | The Zacks Analyst Blog Highlights: Vanguard Total World Stock ETF, iShares MSCI ACWI ETF, SPDR MSCI World Quality Mix ETF and SPDR MSCI ACWI IMI ETF

2016-03-02 10:20:03 | Build a Global Diversified Portfolio with These ETFs

2016-02-23 13:42:31 | Is it time for U.S. investors to look abroad?

2016-02-05 11:37:04 | 4 Global ETFs to Outperform in Q1

2015-04-20 14:45:51 | Why It Is A Good Time To Consider International ETFs

2015-02-24 13:46:44 | Q&A: How Many ETFs Do You Need for a Well-Rounded Portfolio?